You just read:

Amgen Announces Top-Line Results From Phase 3 KYPROLIS® (Carfilzomib) CLARION Study In Newly Diagnosed Multiple Myeloma Patients

News provided by

Amgen

27 Sep, 2016, 04:00 ET